Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 24 Neoplasms 12 Colonic Neoplasms 12 Breast Neoplasms 12 Prostatic Neoplasms 9 Polycythemia Vera 9 Venous Thromboembolism 8 Multiple Myeloma 8 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Thrombocythemia, Essential 4 Ovarian Neoplasms 4 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Myeloproliferative Disorders 4 Barrett Esophagus 4 Precancerous Conditions 3 Melanoma 3 Esophageal Neoplasms 3 Adenomatous Polyps 3 Adenoma 3 Tobacco Use Disorder 2 Thrombosis 2 Thromboembolism 2 Smoking Cessation 2 Sarcoma 2 Primary Myelofibrosis 2 Neoplastic Cells, Circulating 2 Neoplasms by Site 2

Interventions

Exercise 24 Metformin 23 Resistance Training 8 Nutrition Assessment 8 Methods 8 Tirzepatide 7 Diet Therapy 7 Diet 7 Counseling 7 Early Intervention, Educational 6 Caloric Restriction 6 Exenatide 5 semaglutide 4 Liraglutide 4 Educational Status 4 Docosahexaenoic Acids 4 Diet, Mediterranean 4 Vitamin D 3 Therapeutics 3 Surveys and Questionnaires 3 Sugars 3 Standard of Care 3 Dexamethasone 3 Yoga 2 Tablets 2 Specimen Handling 2 Progestins 2 Ovidrel 2 Nutritional Status 2 Naltrexone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Obesity × Aspirin × Clear all

NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡